Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

MARVELD2 Rabbit anti-Human, Mouse, Rat, Polyclonal, Invitrogen™ Non-distribution product as customer accommodation. Available on GSA/VA Contract for Federal Government customers only.

Rabbit Polyclonal Antibody

Manufacturer:  Invitrogen 488400

Catalog No. 48-840-0

Add to cart



This antibody is specific for the Tricellulin/MARVELD-2 protein. On western blots, it identifies the target band at ~64 kDa. Reactivity has been confirmed with human Caco-2, dog MDCK, mouse IMCD-3 cells, and mouse kidney lysates by western blotting, and with mouse MTE7b cells by immunocytochemistry. Based on amino acid sequence homology, reactivity with Rhesus monkey, chimpanzee, rat, bovine, and horse is expected.

Tight junctions form an important barrier of paracellular transport in epithelial cells. Sealing of two adjacent cells at bicellular tight junctions (bTJ), is well described. The main structural components of bicellular tight junctions are claudins and occludin, all tetra membrane-spanning proteins. Less is known about the structure of tricellular tight junctions (tTJ), a point where three adjacent cells are in contact with each other. Tricellulin/MARVELD-2 (MARVEL domain-containing protein 2) is the first protein identified that specifically concentrates in tricellular tight junctions. This protein has four membrane-spanning domains, similar to claudins. Tricellulin expression is high in epithelium-derived tissues, such as small intestine, kidney, and lung. Functional evidence for the role of tricellulin in tight junction formation comes from siRNA studies, where suppression of its expression leads to compromised epithelial barrier and tight junction formation. Mutations in tricellulin can cause nonsyndromic deafness (DFNB49). These loss-of-function mutations remove all or most of a conserved region in the cytosolic domain that binds to the cytosolic scaffolding protein ZO-1, indicating that interaction with other known tight junction proteins plays an important role for the function of tricellulin. An independent study in Pakistani families confirmed the role of tricellulin mutations for hearing impairment.

This product(s) resides on a Fisher Scientific GSA or VA contract. If you are viewing this page as a nonregistered user, the price(s) displayed is List Price. To view your GSA or VA contract pricing, log in using your account number, or become a registered user by contacting one of our Customer Service teams. You can also view your contract price by searching for this item(s) on GSA Advantage. To place an order, contact Fisher Scientific Customer Service.



Recombit protein derived from the C-terminal region of the human Tricellulin protein (AccessionNo. NP_001033692, Q8N4S9), which is identical to rhesus monkey and chimpanzee sequences, and 89% homologous to rat and mouse, 88% homologous to bovine and canine, and 86% homologous to horse sequence
Antigen affinity chromatography
Human, Mouse, Rat
Flow Cytometry, Immunocytochemistry, Immunofluorescence, Western Blot
0.25 mg/mL
PBS with 0.1% sodium azide; pH 7.4
Q8N4S9, Q3UZP0
DFNB49, MARVD2, MRVLDC2, Tric, MARVEL (membrane-associating) domain containing 2, MARVEL domain-containing protein 2, tricellulin
100 μg
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
153562, 218518, 365657
Provide Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit